North America Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery
- Language: English
- Published: September 2012
- Region: North America, United States
TechNavio’s analysts forecast the Global Glucose Monitoring Device market to grow at a CAGR of 4.5 percent over the period 2010–2014. One of the key factors contributing to this market growth is the rise in the worldwide diabetic population. The Global Glucose Monitoring Device market has also been witnessing a trend of self-monitoring the glucose level by using advanced, portable glucose meters. However, frequent recalls of glucose monitoring devices from the market due to manufacturing errors could pose a challenge to the growth of this market. TechNavio’s report, Global Glucose Monitoring Device Market 2010–2014, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions. It analyzes the current Global Blood Glucose Monitoring Device market landscape and its growth prospects. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this market include Hoffman-La Roche, LifeScan, Bayer Diabetes Care, and Abbott Diabetes Care.
Key questions answered in this report:
What will the market size be in 2014 and at what rate will it grow?
What key trends is this market subject to?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?
SHOW LESS READ MORE >
01. Executive Summary
03. Market Coverage
04. Market Landscape
05. Vendor Landscape
06. Buying Criteria
07. Market Growth Drivers
08. Drivers and their Impact
09. Market Challenges
10. Market Trends
11. Key Vendor Analysis
11.1 Hoffman-La Roche
11.3 Bayer Diabetes Care
11.4 Abbott Diabetes Care
12. Other Reports in this Series
List of Exhibits:
Exhibit 1: Global Blood Glucose Monitoring Device Market 2010–2014 (US$ billion)
Exhibit 2: Global Blood Glucose Monitoring Device Market by Geographical Segmentation – 2010
Exhibit 3: Global Blood Glucose Monitoring Device Market by Vendor Segmentation – 2010
TechNavio Announces the Publication of its Report – Global Glucose Monitoring Device Market 2010–2014
TechNavio today launched its report, Global Glucose Monitoring Device Market 2010–2014, which is based on an in-depth study of the Americas and the EMEA and APAC regions. The report aims to aid decision makers understand the road map of this market.
Commenting on the report, an analyst from TechNavio’s Healthcare team said, “The Global Blood Glucose Monitoring Device market is witnessing is a paradigm shift from invasive to non-invasive glucose meters. Vendors have realized the opportunity in the Painless Glucose Monitoring segment and are launching non-invasive or minimally invasive monitoring devices.”
According to the report, the main driver for the Global Blood Glucose Monitoring Device market is the worldwide rise in diabetic patients. The reasons for the increasing number of diabetic patients are hereditary and/or related to changes in lifestyle. This increase in the patient population is encouraging the need to monitor glucose levels at regular intervals to prevent long-term problems.
The study was carried out using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.
Hoffman-La Roche, LifeScan, Bayer Diabetes Care and Abbott Diabetes Care